1374 companies

Cabaletta Bio

Market Cap: US$211.3m

A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

CABA

US$2.36

7D

7.8%

1Y

-44.6%

Tonix Pharmaceuticals Holding

Market Cap: US$210.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

TNXP

US$24.21

7D

-6.9%

1Y

65.8%

Atlantic International

Market Cap: US$210.2m

Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.

ATLN

US$3.50

7D

-23.9%

1Y

-41.2%

BioVersys

Market Cap: CHF 166.6m

A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.

BIOV

CHF 28.50

7D

-13.6%

1Y

n/a

Egetis Therapeutics

Market Cap: SEK 1.9b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

EGTX

SEK 5.40

7D

-5.9%

1Y

22.2%

Ironwood Pharmaceuticals

Market Cap: US$206.3m

A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.

IRWD

US$1.39

7D

-1.4%

1Y

-65.4%

TaiGen Biopharmaceuticals Holdings

Market Cap: NT$6.2b

A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.

4157

NT$8.69

7D

4.1%

1Y

-40.3%

GC Cell

Market Cap: ₩288.5b

Develops cell therapy products.

A144510

₩19,200.00

7D

-6.6%

1Y

-40.2%

Helixmith

Market Cap: ₩286.0b

Develops biologic and natural nutraceutical products.

A084990

₩6,210.00

7D

0.6%

1Y

78.7%

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

BINV

SEK 28.70

7D

-6.4%

1Y

-40.1%

S.Biomedics

Market Cap: ₩282.9b

S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products.

A304360

₩23,850.00

7D

-4.2%

1Y

-29.5%

Dimerix

Market Cap: AU$306.1m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

DXB

AU$0.51

7D

-1.0%

1Y

32.5%

Entrada Therapeutics

Market Cap: US$198.4m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

TRDA

US$5.80

7D

7.0%

1Y

-64.7%

AGP

Market Cap: PK₨55.8b

Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.

AGP

PK₨199.45

7D

3.3%

1Y

79.8%

Botanix Pharmaceuticals

Market Cap: AU$304.0m

Operates as a commercial dermatology company in Australia and the United States.

BOT

AU$0.15

7D

19.2%

1Y

-59.2%

Milestone Pharmaceuticals

Market Cap: US$195.8m

A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.

MIST

US$2.00

7D

4.2%

1Y

30.7%

BioAge Labs

Market Cap: US$194.3m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

BIOA

US$5.42

7D

10.6%

1Y

-74.2%

Sirnaomics

Market Cap: HK$1.5b

An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.

2257

HK$14.46

7D

-11.7%

1Y

322.8%

Sangamo Therapeutics

Market Cap: US$191.0m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

SGMO

US$0.66

7D

21.6%

1Y

-23.4%

Sinphar PharmaceuticalLtd

Market Cap: NT$5.8b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

1734

NT$30.60

7D

0%

1Y

-2.2%

Binh Dinh Pharmaceutical and Medical Equipment

Market Cap: ₫5.0t

Manufactures and trades in pharmaceuticals and medical equipment in Vietnam.

DBD

₫53,600.00

7D

-0.9%

1Y

19.5%

Selvita

Market Cap: zł693.8m

Operates as a contract research organization worldwide.

SLV

zł37.80

7D

0.5%

1Y

-33.5%

Biofarm

Market Cap: RON 810.0m

Manufactures and sells medicines in Romania.

BIO

RON 0.82

7D

-1.0%

1Y

5.7%

Orient Pharma

Market Cap: NT$5.7b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

4166

NT$25.50

7D

-1.7%

1Y

-1.0%

HLB TherapeuticsLtd

Market Cap: ₩262.8b

A biotech company, develops pharmaceutical products in South Korea and internationally.

A115450

₩3,130.00

7D

-6.4%

1Y

-65.8%

Journey Medical

Market Cap: US$185.7m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

DERM

US$7.06

7D

-3.3%

1Y

23.4%

Hester Biosciences

Market Cap: ₹16.5b

Manufactures and trades in veterinary vaccines and animal health products in India and internationally.

524669

₹1,934.50

7D

-3.6%

1Y

-22.2%

Savior Lifetec

Market Cap: NT$5.6b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

4167

NT$17.75

7D

-1.4%

1Y

-17.4%

Diaceutics

Market Cap: UK£137.5m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

DXRX

UK£1.63

7D

8.3%

1Y

21.7%

TTK Healthcare

Market Cap: ₹16.3b

Engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India.

507747

₹1,154.55

7D

-2.6%

1Y

-31.3%

Genfit

Market Cap: €155.9m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

GNFT

€3.13

7D

-13.4%

1Y

-39.5%

Saniona

Market Cap: SEK 1.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

SANION

SEK 12.28

7D

2.2%

1Y

178.5%

Black Diamond Therapeutics

Market Cap: US$177.1m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

BDTX

US$3.40

7D

3.7%

1Y

-19.6%

Syncom Formulations (India)

Market Cap: ₹15.7b

Manufactures, markets, and sells pharmaceutical formulation products in India and internationally.

524470

₹16.71

7D

-6.6%

1Y

-24.0%

Lee's Pharmaceutical Holdings

Market Cap: HK$1.4b

An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.

950

HK$2.30

7D

-7.3%

1Y

93.3%

3billion

Market Cap: ₩245.5b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

A394800

₩7,740.00

7D

4.6%

1Y

n/a

Page 20 of 39